Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

KLRA

Kailera Therapeutics, Inc.

Healthcare · Biotechnology

$12.79Sep 22, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for KLRA yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 0d ago

KLRA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on KLRA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Kailera Therapeutics, Inc. (KLRA) — events, not interpretation.

Event
Last session September 22, 2026 at $12.79.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Kailera Therapeutics, Inc. (KLRA)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Kailera Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$1.42B

KLRA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Kailera Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.